News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mineo Chrysa
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/24/2022 |
4
| Mineo Chrysa (Director) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 28,000 options to buy
@ $0.53, valued at
$14.8k
|
|
| 06/24/2021 |
4
| Mineo Chrysa (Director) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 17,500 options to buy
@ $1.92, valued at
$33.6k
|
|
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2018 |
4
| Mineo Chrysa (Director) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.3, valued at
$58.3k
|
|
| 03/01/2018 |
4
| Mineo Chrysa (Director) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.1, valued at
$142k
|
|
| 08/27/2015 |
4
| Mineo Chrysa (SVP, Corporate Development) has filed a Form 4 on Receptos, Inc.|
Txns:
| Unknown transaction of 104,692 shares
@ $0
Disposed/sold 7,000 shares
@ $0
Disposed/sold 13,333 options to buy
@ $8.1, valued at
$108k
Disposed/sold 30,000 options to buy
@ $18.77, valued at
$563.1k
Disposed/sold 20,000 options to buy
@ $28.37, valued at
$567.4k
Disposed/sold 36,945 options to buy
@ $41.51, valued at
$1.5M
|
|
| 04/03/2015 |
4
| Mineo Chrysa (See Remarks) has filed a Form 4 on Receptos, Inc.|
Txns:
| Granted 7,000 shares
@ $0 |
|
| 11/12/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/07/2014 |
4
| Mineo Chrysa (SVP, Corporate Development) has filed a Form 4 on Receptos, Inc.|
Txns:
| Granted 36,945 options to buy
@ $41.51, valued at
$1.5M
|
|
| 12/26/2013 |
4
| Mineo Chrysa (VP Corporate Development) has filed a Form 4 on Receptos, Inc.|
Txns:
| Granted 20,000 options to buy
@ $28.37, valued at
$567.4k
|
|
| 07/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|